Population Health Sciences

You are here

Publications

Found 37 results
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is O  [Clear All Filters]
Journal Article
Khullar D, Ohn JA, Trusheim M, Bach PB.  2020.  Understanding the Rewards of Successful Drug Development - Thinking Inside the Box.. N Engl J Med. 382(5):473-480.
Kamel H, Okin PM, Merkler AE, Navi BB, Campion TR, Devereux RB, Díaz I, Weinsaft JW, Kim J.  2019.  Relationship between left atrial volume and ischemic stroke subtype.. Ann Clin Transl Neurol. 6(8):1480-1486.
Yin MT, RoyChoudhury A, Bucovsky M, Colon I, Ferris DC, Olender S, Agarwal S, Sharma A, Zeana C, Zingman B et al..  2019.  A Randomized Placebo-Controlled Trial of Low- Versus Moderate-Dose Vitamin D3 Supplementation on Bone Mineral Density in Postmenopausal Women With HIV.. J Acquir Immune Defic Syndr. 80(3):342-349.
Frey MK, Kahn RM, Chapman-Davis E, Tubito F, Pires M, Christos P, Anderson S, Mukherjee S, Jordan B, Blank SV et al..  2020.  Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.. J Clin Oncol. 38(13):1389-1397.
Shoag J, Liu D, Ma X, Oromendia C, Christos P, Ballman K, Angulo C, Cai PY, Gaffney C, Klein E et al..  2020.  Prognostic value of the SPOP mutant genomic subclass in prostate cancer.. Urol Oncol.
Brown B, O'Donnell E, Casalino LP.  2019.  Private Equity Investment in Behavioral Health Treatment Centers.. JAMA Psychiatry.
Casalino LP, Saiani R, Bhidya S, Khullar D, O'Donnell E.  2019.  Private Equity Acquisition of Physician Practices.. Ann Intern Med. 171(1):78.
Awad SF, O'Flaherty M, El-Nahas KG, Al-Hamaq AO, Critchley JA, Abu-Raddad LJ.  2019.  Preventing type 2 diabetes mellitus in Qatar by reducing obesity, smoking, and physical inactivity: mathematical modeling analyses.. Popul Health Metr. 17(1):20.
Press MJ, Gerber LM, Peng TR, Pesko MF, Feldman PH, Ouchida K, Sridharan S, Bao Y, Barron Y, Casalino LP.  2015.  Post-Discharge Communication Between Home Health Nurses and Physicians: Measurement, Quality, and Outcomes.. J Am Geriatr Soc. 63(7):1299-305.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al..  2020.  Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.
Tagawa ST, Vallabhajosula S, Christos PJ, Jhanwar YS, Batra JS, Lam L, Osborne J, Beltran H, Molina AM, Goldsmith SJ et al..  2019.  Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( Lu-J591) for metastatic castration-resistant prostate cancer.. Cancer. 125(15):2561-2569.
Hajifathalian K, Kumar S, Newberry C, Shah S, Fortune B, Krisko T, Ortiz-Pujols S, Zhou XKathy, Dannenberg AJ, Kumar R et al..  2020.  Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City.. Obesity (Silver Spring).
Mehta B, Goodman S, DiCarlo E, Jannat-Khah D, J Gibbons AB, Otero M, Donlin L, Pannellini T, Robinson WH, Sculco P et al..  2023.  Machine learning identification of thresholds to discriminate osteoarthritis and rheumatoid arthritis synovial inflammation.. Arthritis Res Ther. 25(1):31.
Mehta B, Goodman S, DiCarlo E, Jannat-Khah D, J Gibbons AB, Otero M, Donlin L, Pannellini T, Robinson WH, Sculco P et al..  2023.  Machine learning identification of thresholds to discriminate osteoarthritis and rheumatoid arthritis synovial inflammation.. Arthritis Res Ther. 25(1):31.
Xu J, Mao C, Hou Y, Luo Y, Binder JL, Zhou Y, Bekris LM, Shin J, Hu M, Wang F et al..  2022.  Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's disease.. Cell Rep. 41(9):111717.
D'Onofrio G, E Edelman J, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, Martel SH, VanVeldhuisen P, Oden N, Murphy SM et al..  2019.  Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).. Implement Sci. 14(1):48.
D'Onofrio G, E Edelman J, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, Martel SH, VanVeldhuisen P, Oden N, Murphy SM et al..  2019.  Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).. Implement Sci. 14(1):48.
D'Onofrio G, E Edelman J, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, Martel SH, VanVeldhuisen P, Oden N, Murphy SM et al..  2019.  Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).. Implement Sci. 14(1):48.
Vest JR, Jung H-Y, Ostrovsky A, Das LTanmoy, McGinty GB.  2015.  Image Sharing Technologies and Reduction of Imaging Utilization: A Systematic Review and Meta-analysis.. J Am Coll Radiol. 12(12 Pt B):1371-1379.e3.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.